Back to top

Image: Bigstock

MO Q3 Earnings Call Highlights Higher Guidance and Nicotine Strategy

Read MoreHide Full Article

Key Takeaways

  • Altria's Q3 adjusted EPS rose 4.8% to $1.52, while revenues net of excise taxes grew 3.6% to $5.44B.
  • MO raised 2026 adjusted EPS guidance to $5.66-$5.74 as cigarette pricing supports resilient profitability.
  • Altria's on! shipments climbed 13.3%, dividends and buybacks returned over $6B to shareholders in 9 months.

Altria Group, Inc. (MO - Free Report) emphasized pricing discipline, smoke-free innovation and shareholder returns during its third-quarter 2026 earnings call. Management raised its full-year earnings outlook, supported by resilient profitability in its core cigarette business.

Executives highlighted growth in the on! nicotine pouch portfolio, evolving regulatory developments and continued pressure on consumer spending. Analyst questions focused on cigarette volumes, export-related benefits and the profitability of emerging nicotine products.

MO Q3 Earnings Beat Estimates on Higher Revenues

Altria reported third-quarter adjusted earnings of $1.52 per share, exceeding the Zacks Consensus Estimate of $1.51. Earnings increased 4.8% year over year from $1.45 per share.

Revenues net of excise taxes increased 3.6% to $5.44 billion, surpassing the Zacks Consensus Estimate of $5.3 billion. Total net revenues increased 1% to $6.13 billion.

Altria Group, Inc. Price, Consensus and EPS Surprise

Altria Group, Inc. Price, Consensus and EPS Surprise

Altria Group, Inc. price-consensus-eps-surprise-chart | Altria Group, Inc. Quote

GAAP earnings rose 7.1% to $1.51 per share. Adjusted operating income in smokeable products increased 3.9% to $3.07 billion, while adjusted operating margin expanded 10 basis points to 64.5%.

Altria Raises Full-Year Earnings Outlook

Executive Vice President and chief financial officer Heather Newman raised full-year adjusted earnings guidance to $5.66-$5.74 per share, representing 4.5-6% growth from the 2025 base of $5.42.

Responding to a Stifel analyst, Newman attributed the increase to strong performance during the first nine months while maintaining investment in smoke-free products.

Management emphasized that its outlook incorporates persistent consumer spending pressures, planned investments and continued uncertainty surrounding nicotine category dynamics.

MO Defends Cigarette Profitability Amid Volume Pressure

Newman highlighted PM USA's pricing and portfolio strategies as central to maintaining profitability despite declining cigarette consumption.

Reported domestic cigarette shipments declined 2.9%, while inventory-adjusted volumes fell an estimated 4%, compared with an estimated 5% industry decline. Marlboro maintained a 60% share of the premium segment.

During questioning from UBS, CEO Salvatore Mancuso emphasized Cowboy Cut's role in retaining price-sensitive Marlboro consumers. He also attributed moderating industry volume declines partly to reduced consumer movement into illicit e-vapor products.

Altria Expands on! Amid Intense Competition

Mancuso highlighted continued investment in Helix's on! nicotine pouch portfolio, including higher-strength products and additional flavors.

On! shipment volumes increased 13.3% to 47.8 million cans. Its oral tobacco category retail share reached 8.3%, increasing 0.1 percentage point year over year but declining 0.3 percentage point sequentially.

Responding to Barclays, Mancuso explained that new product launches contributed to some inventory movements. Management remains focused on expanding distribution, improving retail visibility and developing the brand despite competitive pricing pressures.

MO Seeks Regulatory Clarity for Smoke-Free Products

Mancuso discussed legal action initiated by Helix and NJOY seeking a more predictable FDA product authorization process.

Management welcomed the FDA's subsequent announcement of plans to reconsider its premarket tobacco application framework. Altria also emphasized sustained enforcement against unauthorized e-vapor products.

During questioning from Goldman Sachs, Mancuso confirmed plans to return NJOY ACE to the market without specifying timing. He emphasized profitability and disciplined investment as priorities for the business.

Altria Expands Shareholder Returns

Management highlighted strong cash generation supporting dividends, repurchases and investment in emerging products.

The company returned more than $6 billion to its shareholders during the first nine months, including $5.3 billion in dividends and $735 million through repurchases.

Newman confirmed a $1 billion expansion of the share repurchase authorization through December 2027. The company also increased its quarterly dividend by 4.7% to $1.11 per share, maintaining its progressive dividend growth objective.

MO Maintains a Disciplined Growth Approach

Management's overarching message emphasized protecting profitability in established tobacco operations while investing selectively in smoke-free alternatives.

Mancuso and Newman maintained confidence in the company's financial outlook but acknowledged continued economic pressure on consumers, competitive nicotine markets and regulatory uncertainty.

What Zacks Rank and Style Scores Indicate for MO

MO currently carries a Zacks Rank #2 (Buy), indicating a favorable near-term earnings estimate revision outlook under the Zacks framework. Its Value and Growth Score of C each indicates middling characteristics in those investment styles.

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

However, the stock's Momentum Score of D and VGM Score of D indicate weaker momentum characteristics and a less favorable combination of value, growth and momentum factors. These scores temper the positive signal from its Zacks Rank.

Although the Zacks Rank #2 indicates favorable relative performance potential over the next one to three months, the weaker Style Scores limit the strength of the combined signals. The Zacks Rank can change as analysts revise earnings estimates following the latest quarterly results.

Published in